{"schema":"rootz.ai/sec-company/v1","layer":0,"identity":{"name":"NewcelX Ltd.","cik":"0001783036","ticker":"NCEL","exchange":"Nasdaq","sic":"2834","sic_description":"Pharmaceutical Preparations","state_of_incorporation":"V8","headquarters":null,"founded":null,"ipo_date":null,"status":"active"},"summary":"NLS (NewcelX Ltd.) is a company pursuing a merger with Kadimastem, an Israeli cell therapy company. Following the merger, NLS intends to shift its business focus to developing and manufacturing off-the-shelf, allogeneic, proprietary cell products. The filing primarily discusses merger-related risks, conditions, and terms rather than detailing current commercial products or services.","peak_metrics":{"market_cap_usd":null,"market_cap_date":null,"employees":null,"employees_date":null,"rd_spend_usd":null,"rd_spend_year":null},"tags":["cell-therapy","biotechnology"],"deeper":{"profile":"/api/company/NCEL/profile","timeline":"/api/company/NCEL/timeline","filings":"/api/company/NCEL/filings","people":"/api/company/NCEL/people","skill":"/api/skills/NCEL","skill_json":"/api/skills/NCEL?format=json"},"data_freshness":{"latest_filing":"2026-04-01","latest_extracted":"2026-04-01","latest_quote":"2026-08-06"},"origin":{"leaf":"5dab58f1ad352bdd15dc14b83f4ad4a017b74f8c4b915e23547e20c944528701","parent":"1dd6aedd0603796525aa76b52ca8e8b266e4973e811f4b66435f715c4815afa8","timestamp":"2026-08-13T00:33:17.948Z","source":"0001213900-25-044868","chain":"SEC.gov PEM > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Hash this response content + parent + timestamp to reproduce the leaf hash","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin chain (see origin.leaf) traceable to an SEC-signed source. It is UNVERIFIED until validated.","how_to_validate":"GET https://origin.rootz.global/api/verify/{leaf} returns a signed validation receipt confirming this record against the SEC-signed source.","chain":"SEC.gov filing (government signature) then origin.rootz.global extraction then this response.","licensing":"Reading is free. Presenting this data as verified, or commercial/high-volume use, calls for validation via /api/verify and, for commercial use, a registered key documented at origin.rootz.global/dashboard.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":121,"hourly_limit":500,"remaining":379,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"unverified — GET https://origin.rootz.global/api/verify/{leaf} for a signed validation receipt before citing","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}